University of Nevada, Las Vegas, NV, U.S.A.
World Journal of Advanced Research and Reviews, 2026, 30(03), 716-722
Article DOI: 10.30574/wjarr.2026.30.3.1630
Received on 02 May 2026; revised on 08 June 2026; accepted on 10 June 2026
Biopharmaceutical innovations have redefined treatment strategies across diverse diseases. From monoclonal antibodies and mRNA vaccines to gene and CAR-T cell therapies, these biologically derived agents offer unprecedented specificity and effectiveness. Biosimilars are making advanced treatments more accessible, while cutting-edge delivery systems are enhancing patient compliance. Personalized medicine is ushering in a new era of tailored care, optimizing outcomes based on individual profiles. Alongside scientific progress, improvements in manufacturing and quality control are ensuring scalability and safety. Despite regulatory challenges, ongoing research continues to expand the therapeutic frontier, promising a future of more effective and personalized disease management.
Biopharmaceutical; Monoclonal Antibodies; Ribonucleic Acids (RNA); Gene-Based Vectors; Therapeutics Enzymes
Preview Article PDF
Parulben Patel. Biopharmaceutical breakthroughs in modern therapeutics. World Journal of Advanced Research and Reviews, 2026, 30(03), 716-722. Article DOI: https://doi.org/10.30574/wjarr.2026.30.3.1630